SCHEMBL4448525

SCHEMBL4448525

CCCCOC(=O)N1CCCC(COS(=O)(=O)c2ccc(C)cc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MMP3 P08254 2/20 0.42
MMP9 P14780 2/20 0.42
MMP13 P45452 2/20 0.42
MMP1 P03956 1/20 0.42
MMP7 P09237 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 2/20 0.41
MMP2 P08253 1/20 0.41
MMP8 P22894 1/20 0.41
FKBP1A P62942 1/20 0.40
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25199281 0.94 ALDH1A1 (0.46) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL30058727 0.89 KMT2A (0.44) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL4012966 0.87 ALDH1A1 (0.50) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL18173570 0.84 CYP2D6 (0.46) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL23250054 0.83 KMT2A (0.46) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL7350346 0.83 BCL9 (0.48) ALDH1A1MMP3MMP9MMP13MMP1
SCHEMBL5662056 0.82 EPHX2 (0.45) ALDH1A1GAAPOLBPKMLMNA
SCHEMBL3656085 0.82 POLB (0.43) ALDH1A1MMP3MMP9MMP13MMP1
SCHEMBL4398358 0.82 EPHX2 (0.45) ALDH1A1GAAPOLBPKMLMNA
SCHEMBL2460370 0.82 EPHX2 (0.45) ALDH1A1GAAPOLBPKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635822-A4 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARM INC (US) 2009-06-24 EP disclosed
EP-1635871-A4 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARM INC (US) 2007-07-18 EP disclosed
EP-1635871-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP disclosed
EP-1635822-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS Elan Pharmaceuticals, Inc. (US) 2006-03-22 EP disclosed
WO-2005000244-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARMACEUTICALS, INC. (US) 2005-01-06 WO disclosed
WO-2005000246-A2 METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS ELAN PHARMACEUTICALS, INC. (US) 2005-01-06 WO disclosed